Skip to main content
Erschienen in: European Radiology 2/2021

Open Access 26.08.2020 | Neuro

Reporting frequency of radiology findings increases after introducing visual rating scales in the primary care diagnostic work up of subjective and mild cognitive impairment

verfasst von: Claes Håkansson, Gustav Torisson, Elisabet Londos, Oskar Hansson, Isabella M. Björkman-Burtscher, Danielle van Westen

Erschienen in: European Radiology | Ausgabe 2/2021

Abstract

Objectives

Study the effect of introducing a template for radiological reporting of non-enhanced computed tomography (NECT) in the primary care diagnostic work up of cognitive impairment using visual rating scales (VRS).

Methods

Radiology reports were assessed regarding compliance with a contextual report template and the reporting of the parameters medial temporal lobe atrophy (MTA), white matter changes (WMC), global cortical atrophy (GCA), and width of lateral ventricles (WLV) using established VRS in two age-matched groups examined with NECT before (n = 111) and after (n = 125) the introduction of contextual reporting at our department. True positive rate (TPR) and true negative rate (TNR) before and after were compared.

Results

We observed a significant increase in the percentage of radiology reports with mentioning of MTA from 29 to 76% (p < 0.001), WMC from 69 to 86% (p < 0.01), and GCA from 54 to 82% (p < 0.001). We observed a significant increase in the percentages of reports where all of the parameters were mentioned, from 6 to 29% (p < 0.001). There was a significant increase in TPR from 10 to 55% for MTA.

Conclusion

This study suggests that contextual radiological assessment using VRS could increase the reporting frequency of radiology findings in the diagnostic work up of cognitive impairment but compliance with templates may be difficult to endorse.

Key Points

• Introducing visual rating scales in clinical practice increases the reporting frequency of MTA, WMC, and GCA in the diagnostic work up of subjective and mild cognitive impairment.
• Introducing visual rating scales has an effect on the true positive rate of reported MTA.
• Compliance with contextual radiology templates remains low when use of the template is not enforced by the department leadership.
Hinweise

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AD
Alzheimer’s disease
BioFINDER
Biomarkers for identifying neurodegenerative disorders early and reliably
CI
Confidence interval
CSF spaces
Cerebrospinal fluid spaces
CT
Computed tomography
EI
Evans’ index
GCA
Global cortical atrophy
HU
Hounsfield units
MRI
Magnetic resonance imaging
MTA
Medial temporal lobe atrophy
NECT
Non-enhanced computed tomography
PACS
Picture archiving and communication system
TNR
True negative rate
TPR
True positive rate
VRS
Visual rating scales
WLV
Width of lateral ventricles
WMC
White matter changes

Introduction

The work of the radiologist includes interpretation of images and communicating relevant findings through the radiology report. Traditionally, radiology reports have been free narratives with variations in structure and quality [1, 2]. The form of the radiology report has been debated and structured reporting has been suggested as a method to improve quality; however, consensus regarding form and style has not been reached [37].
Recently, contextual reporting has been suggested as an intermediate between structural reporting and free narrative reporting [8]. Contextual reports are structured in a disease-specific way with findings reported in a checklist manner but they are less strict compared with structural reporting. Another method to potentially improve quality is the use of established visual rating scales (VRS). An example from the field of neuroradiology is VRS developed for the investigation of cognitive impairment, which are endorsed in clinical practice [911].
Previous studies have shown that structural findings are underreported in the diagnostic work up of cognitive impairment [1214]. A recent European survey showed that VRS were used in 75% of responding centers but structural reporting was used in only 28% [15]. In order to improve accuracy and clarity of radiology reports, our department introduced contextual reports as an endorsed routine. The purpose of this study is to investigate the effect on reporting of structural radiological findings after introducing a template with VRS in the primary care diagnostic work up of cognitive impairment.

Materials and methods

Materials

This is a retrospective, observational, single-center study. Eligible subjects, aged 60 to 80 years, were retrospectively recruited for two age-matched groups with exams performed before and after the introduction of contextual reporting; non-enhanced computed tomography (NECT) is the preferred modality in our country due to greater availability [16]. Only referrals issued by general physicians as part of a primary care diagnostic work up of cognitive impairment (the routine in our country) were eligible for inclusion.
We searched our picture archiving and communication system (PACS) for referrals containing the words “dementia” and/or “memory” together with the word “investigation” to identify eligible subjects under primary care investigation for subjective or mild cognitive impairment. Since our purpose was to study the effect of introducing VRS in the primary diagnostic work up, subjects where referrals mentioned known dementia or psychiatric disorder were not eligible for inclusion.
The group “before” was retrospectively recruited from the Swedish BioFINDER study mild cognitive impairment (MCI) cohort (see https://​biofinder.​se/​ for more detail) where eligible subjects had performed a routine NECT available in our PACS from January 2010 to December 2014. Some subjects (n = 68) in this group have been included in a previous study but all results are new for this study [14]. The group “after” was retrospectively recruited from our PACS from January 2016 to December 2017. To mimic the clinical situation, we had only access to clinical information given in the referrals.
Our endorsed template (see Fig. 1) states that medial temporal lobe atrophy (MTA), white matter changes (WMC), global cortical atrophy (GCA), and width of lateral ventricles (WLV) must be reported. The use of established VRS is endorsed [11]. All reports must end with an “Impression” where findings should be interpreted and probable diagnosis listed. For this study, any additional findings mentioned in the reports were not included in the evaluation. Full compliance was defined as reports including all evaluated parameters and an “Impression.”

Assessment of exams

All NECT images were rated in a second reading by an experienced neuroradiologist (C.H.). Visual rating of MTA was done on coronal reformats with 3 mm slices (parallel to the axis of the brain stem) and graded from 0 = no atrophy to 4 = severe atrophy according to Scheltens’ MTA scale. Each side was rated separately and the overall highest score was given. Ratings were dichotomized into normal (0–1 if < 75 years, 0–2 if ≥ 75 years) and abnormal (2–4 if < 75 years, 3–4 if ≥ 75 years) [17, 18]. For rating of GCA, Pasquier’s scale was used on axial reformats in 5 mm slices (parallel to the orbitomeatal plane) and graded from 0 = no cortical atrophy to 3 = severe cortical atrophy [11, 19]. Grades were dichotomized into normal (0–1 regardless of age) and abnormal (2–3 regardless of age) based on previous studies [12, 14]. Fazekas’ scale was used to grade WMC with four grades from 0 = none or a single lesion to 3 = confluent lesions and dichotomized into normal (0 < 65 years, 0–1 ≥ 65 years) and abnormal (1–3 < 65 years, 2–3 ≥ 65 years) [11, 12, 20]. Evans’ index (EI) was measured on axial slices as an estimation of WLV. Cutoffs corrected for age and gender suggested by Brix et al were used (age: males/females); 65–69 years, 0.34/0.32; 70–74 years, 0.36/0.33; and 75–79 years, 0.37/0.34 [21, 22]. For 60–64 years, ≥ 0.30 was considered abnormal regardless of gender.
All NECT exams were performed according to our clinical routine with helical scan mode using Z-axis dose modulation on scanners from three different vendors with 120 kV voltage, exposure from 150 to 320 mAs, collimation from 0.5 to 0.75, and pitch factor from 0.36 to 0.65. Image quality was considered equal between scanners. All readings were done in our PACS IDS7® (Sectra AB) with a center width of 40 HU and window width of 80 HU.

Assessment of clinical reports

All reports were reassessed and graded according to a scale by Torisson et al [12] and applied in accordance with a previous study [14] with respect to quantitative (e.g., “mild,” “severe”) and qualitative (e.g., “widened,” “enlarged”) descriptions of the evaluated parameters. Examples of how reports were graded are given in Table 1. Reports were graded as NA = not mentioned, 0 = normal (corresponds to MTA 0, GCA 0, and WMC 0), 1 = mild or reported but not quantified (corresponds to MTA 1–2, GCA 1, and WMC 1), 2 = moderate (corresponds to MTA 3, GCA 2, and WMC 2), and 3 = severe (corresponds to MTA 4, GCA 3, and WMC 3) [12]. For MTA, GCA, and WMC, a grade of ≥ 2 was considered abnormal. For WLV, a grade of ≥ 1 was considered abnormal. The gradings were compared with the second reading for estimation of true positive rate (TPR) and true negative rate (TNR). For this, we assumed that all reports where evaluated parameters had not been mentioned were assessed as normal. Since visual ratings are subjective, an additional rating was performed after 4 weeks for estimation of intra-rater agreement. Additionally, a second rater (D.v.W.) performed an assessment of GCA, MTA, and WMC on 100 randomly selected subjects (50 from each group) for estimation of inter-rater agreement and the rating with the highest inter-rater agreement was chosen as standard for the second reading.
Table 1
Examples from radiology reports and our quantification and grading in accordance with the scale by Torisson et al [12]
Examples from reports
Findings mentioned
Grading
Comment
WLV
GCA
MTA
WMC
WLV
GCA
MTA
WMC
“No abnormal changes”
No
No
No
No
NA
NA
NA
NA
No findings reported
“Normal attenuation of parenchyma. Normal CSF spaces. No atrophy”
Yes
Yes
No
Yes
0
0
NA
0
“Attenuation” interpreted as WMC. CSF spaces interpreted as WLV. MTA not mentioned
“No focal changes. Age adequate CSF spaces”
Yes
No
No
Yes
0
NA
NA
0
“Focal changes” interpreted as WMC. “Age adequate” interpreted as normal
“Mild WMC. Mild general atrophy. Increased width of ventricles”
Yes
Yes
No
Yes
1
1
NA
1
WLV mentioned but not graded. MTA not reported
“No ischemic lesion. Normal CSF spaces. No medial temporal lobe atrophy”
Yes
No
Yes
Yes
0
NA
0
0
“Ischemic lesion” interpreted as WMC. GCA not mentioned
“Increased width of lateral ventricles. Some atrophy. Medial temporal lobe atrophy, grade 3. Severe white matter changes”
Yes
Yes
Yes
Yes
1
1
2
3
ELV and GCA reported but not graded. MTA 3 interpreted as moderate
Scale by Torisson et al: NA = not mentioned in report, 0 = reported as normal, 1 = reported as mild or reported but not quantified, 2 = reported as moderate, 3 = reported as severe. MTA medial temporal lobe atrophy, GCA global cortical atrophy, WMC white matter changes, WLV with of lateral ventricles, CSF spaces cerebrospinal fluid spaces

Statistics

Descriptive statistics (percentages) were estimated to summarize results of the gradings and the second reading. True positive rate and TNR were calculated using MEDCALC® (MedCalc Software Ltd.) online statistics calculator (available at https://​www.​medcalc.​org/​calc/​diagnostic_​test.​php) where 95% confidence intervals (95% CI) were visually compared for statistical significance. Difference between groups was compared using Pearson chi-square analysis and Mann-Whitney U test where applicable. For estimation of intra- and inter-rater agreement, Cohen’s κ was estimated for dichotomized data. The level of agreement was defined according to Landis and Koch [23]. Calculations were done using SPSS® version 26 (IBM Corporation). A p < 0.05 was considered statistically significant.

Results

We identified 251 eligible subjects, ten subjects had cancelled examinations, four subjects had failed to perform the exam, and the referral was unclear for one subject. These were excluded and 236 subjects were included with 111 examined “before” and 125 “after” the introduction of contextual reporting. There were no significant differences between the groups with respect to prevalence of abnormal findings and gender. Subjective cognitive impairment was the reported symptom in 97% of all subjects (see Table 2 for demographic data). Evans’ index was only reported for one subject and was included in WLV.
Table 2
Data on subjects and prevalence of evaluated parameters for the two groups “before” and “after”
 
“before”
“after”
p value
Subjects
  Number of subjects (n)
111
125
-
  Age in years (median, interquartile range)
72 (7.8)
73 (7.3)
0.02*
  Females
47%
49%
0.76
Clinical symptom (as reported in referrals)
  Subjective cognitive impairment
95%
98%
0.19
  Personality changes
7%
2%
0.03
  Confusion
1%
2%
0.63
Prevalence (abnormal in the second reading)
  Abnormal MTA
18%
18%
0.93
  Abnormal WMC
25%
22%
0.51
  Abnormal GCA
17%
22%
0.39
  Abnormal WLV
17%
15%
0.69
Significant differences are italicized. Pearson chi-square except *Mann-Whitney U test; p < 0.05 represents a significant difference. MTA medial temporal lobe atrophy, GCA global cortical atrophy, WMC white matter changes, WLV with of lateral ventricles
Intra-rater agreement was excellent for MTA κ = 0.82 95% CI (0.72 to 0.91), p < 0.001 and WLV κ = 0.87 95% CI (0.78 to 0.96), p < 0.001; substantial for WMC κ = 0.79 95% CI (0.70 to 0.88), p < 0.001; and moderate for GCA κ = 0.57 95% CI (0.44 to 0.71), p < 0.001. The highest inter-rater agreement for 100 randomly selected subjects showed substantial agreement for MTA κ = 0.73 95% CI (0.55 to 0.92), p < 0.001; excellent agreement for WMC κ = 0.81 95% CI (0.69 to 0.94), p < 0.001; and fair agreement for GCA κ = 0.44 95% CI (0.19 to 0.70), p < 0.001.
Data on grading of clinical reports and concordance with our second reading are summarized in Table 3. In total, MTA was reported in 54% of the reports. The corresponding number for WMC, GCA, and WLV was 78%, 69%, and 59% respectively. Where MTA was reported as moderate to severe (i.e., Torisson’s scale grades 2–3), 88% was correctly reported as abnormal compared with the second reading. Medial temporal lobe atrophy was reported as mild (i.e., grade 1), in 18% of the reports. The corresponding number in the second reading was 45%; when age correction was applied, 36% was normal and 9% abnormal of which 0% (n = 0) was correctly reported as abnormal. Where WMC was reported as moderate to severe, 83% was correctly reported as abnormal compared with the second reading. White matter changes were reported as mild in 31% of the reports; the corresponding number in the second reading was 18%; when age correction was applied, 17% was normal and 1% abnormal of which 0% (n = 0) was correctly reported as abnormal. Where GCA was reported as moderate to severe, 47% was correctly reported as abnormal, and for WLV, the figure was 38% compared with the second reading.
Table 3
Grading of clinical reports and concordance with second reading
 
Clinical report
Second reading
Abnormal in second reading
Normal in second reading
Correctly reported as abnormal in clinical report
Total abnormal in second reading
MTA
     
18%
  “0”
29%
47%
--
47%
--
 
  “1”
18%
45%*
9%1
36%1
0%
 
  “2”
5%
6%
6%
--
4%
 
  “3”
2%
2%
2%
--
2%
 
  “NA”
46%
--
--
--
--
 
WMC
     
23%
  “0”
27%
60%
--
60%
--
 
  “1”
31%
18%
1%2
17%2
0%
 
  “2”
10%
9%
9%
--
7%
 
  “3”
10%
13%
13%
--
10%
 
  “NA”
22%
--
--
--
--
 
GCA
     
19%
  “0”
31%
27%
--
27%
--
 
  “1”
30%
54%
--
54%
--
 
  “2”
7%
18%
18%
--
3%
 
  “3”
< 1%
1%
1%
--
< 1%
 
  “NA”
31%
--
--
--
--
 
WLV
     
16%
  “0”
39%
84%
--
84%
--
 
  “1”+“2”+“3”5
20%
16%
16%
--
8%
 
  “NA”
41%
--
--
--
--
 
All values are rounded to the nearest integer and represents percentages of total (N = 236) study population. *Sum of MTA 1 (27%) and MTA 2 (18%) in the second reading. 1Corrected for age where MTA 2 is abnormal if age < 75 years. 2Corrected for age where WMC 1 is abnormal if age < 65 years. 5Sum of “1” + “2” + “3,” enlarged WLV dichotomized according to age-corrected cutoffs suggested by Brix et al [22]. The scale by Torisson et al [12]: NA = not mentioned in report, 0 = reported as normal, 1 = reported as mild or reported but not quantified, 2 = reported as moderate, 3 = reported as severe. MTA medial temporal lobe atrophy, GCA global cortical atrophy, WMC white matter changes, WLV width of lateral ventricles
Data on frequencies and compliance, including differences between the groups, are summarized in Table 4. Reporting of MTA, WMC, and GCA increased significantly. There was no significant change in the reporting of WLV. Altogether, the percentage of reports with all parameters mentioned increased from 6% (n = 7) to 29% (n = 36). Full compliance remained low; the percentage of reports in strict full compliance with the template increased from 2% (n = 2) to 8% (n = 10).
Table 4
Percentage of original reports mentioning the evaluated parameters outlined in the contextual reporting template and compliance with contextual reporting for the two groups “before” and “after”
 
“before” (n = 111)
“after” (n = 125)
p*
Evaluated parameter
Percentage of original reports with parameters mentioned
  MTA
29%
76%
< 0.001
  WMC
69%
86%
< 0.01
  GCA
54%
82%
< 0.001
  WLV
55%
62%
0.25
 
Percentage of original reports with all parameters mentioned
All parameters reported
6%
29%
< 0.001
*Pearson chi-square, p < 0.05 represents a significant increase in percentage of reports with the evaluated parameter mentioned, significant changes are italicized. MTA medial temporal lobe atrophy, GCA global cortical atrophy, WMC white matter changes, WLV with of lateral ventricles
Results regarding TPR and TNR are summarized in Table 5. A significant increase in TPR was observed for MTA with an increase from 10 to 55%. There were no significant changes in TPR for the other parameters but an increase from 0 to 33% was observed for GCA and an increase from 37 to 58% was observed for WLV. There was high to almost perfect TNR with no significant changes for any parameter in the two groups.
Table 5
True positive rate and true negative rate for the evaluated parameters, expressed as percentages, of original reports in the two groups “before” and “after”
 
“before” (n = 111)
“after” (n = 125)
Evaluated parameter
MTA
WMC
GCA
WLV
MTA
WMC
GCA
WLV
TPR % (95% CI)
10 (1–32)
68 (48–84)
0 (0–18)
37 (16–62)
55 (32–76)
78 (58–91)
33 (17–54)
58 (34–80)
TNR % (95% CI)
99 (94–100)
99 (93–100)
96 (89–99)
88 (80–94)
99 (95–100)
93 (86–97)
94 (87–98)
82 (73–89)
Significant changes are italicized. MTA medial temporal lobe atrophy, GCA global cortical atrophy, WMC white matter changes, WLV width of lateral ventricles, 95% CI 95% confidence interval, TPR true positive rate, TNR true negative rate

Discussion

In this retrospective, observational study, we evaluated compliance and compared TPR of radiology reports before and after the introduction of contextual reporting in the diagnostic work up of cognitive impairment. We found an increase in the reporting of MTA, GCA, and WMC and an increased TPR for MTA. Although an increase in the reporting of evaluated parameters was observed, full compliance with the template remained low (8%) and the percentage of reports where all parameters were mentioned only reached 29%. Due to small numbers, it is difficult to draw any definitive conclusions from the reports with full compliance or mentioning of all parameters why we chose to evaluate each parameter separately.
We had anticipated that full compliance would reach at least 50% why our results would seem disappointing. In a study by Powell et al, 9% compliance was observed when a structured template for assessing maxillofacial trauma was evaluated [24]. This figure is close to our result but differences in methodology make further comparisons difficult. Another study by Larson et al showed that structured reporting could successfully be implemented if enforced by the department leadership [4]. Since visual ratings are subjective, it has also been suggested that differences in structure of radiology reports may be explained by local traditions and, in the case of cognitive impairment, imaging has traditionally been used to exclude secondary causes to cognitive impairment [25, 26]. Taking all of this into consideration, we believe our observed low compliance is similar to what have been previously reported and could be explained by adherence to local traditions. Also, the use of our template was not enforced by the department leadership.
Previous studies have shown that abnormal findings, in particular MTA, are underreported in radiology reports even when assessment is warranted [12, 14]. Medial temporal lobe atrophy is an important structural finding in Alzheimer’s disease (AD) but it can also be found in other dementias [27, 28]. Our results showed an increase in reporting and TPR for MTA. Moderate to severe MTA was correctly reported as abnormal in 88% but mild atrophy was underreported; also, when age correction was applied, there remained an underreporting of abnormal mild atrophy (i.e., MTA 2 in subjects < 75 years). The underreporting of mild MTA probably explains the observed low TPR (10% “before” and 55% “after”) for MTA and it cannot be excluded that a study population with a higher prevalence of moderate to severe MTA would have resulted in better TPR and compliance. In line with previous studies, excellent intra-rater and substantial inter-rater agreement was observed for MTA [14, 29]. With respect to the clinical importance of MTA and previously observed underreporting, we believe our results regarding MTA have an important clinical impact [12, 14].
The reporting of GCA increased significantly, although TPR remained low (33%). Where abnormal GCA was reported, it was erroneous in 53% which probably explains our observed low TPR. The GCA scale covers a larger brain region compared with the MTA scale. Although ratings are based on the highest grade of atrophy, the risk of potential underreporting cannot be eliminated since moderate parietal cortical atrophy and mild frontal cortical atrophy still could be interpreted as overall mild GCA (normal) by one rater and moderate GCA (abnormal) by another. This would probably also explain our observed levels of agreement.
There was an increase in the reporting of WMC and WLV, where the increase for WMC was significant, but changes in TPR were not significant. In many reports, the phrase “normal appearing cerebrospinal fluid spaces” (CSF spaces) was used. This resulted in difficulties in our grading of the reports since this could mean normal width of sulci (i.e., normal GCA) and normal WLV combined. We chose to interpret this as normal WLV. White matter changes are preferably assessed on magnetic resonance imaging (MRI), but for abnormal findings, NECT is considered sufficient [9, 11]. In other words, when WMC is reported on NECT, it is most likely to be Fazekas grade 2 or 3. Our results showed that moderate to severe WMC was reported in 20% of the reports compared with 22% in the second reading while mild changes were overreported. In most reports, the phrases “white matter changes” or “focal parenchymal changes” were used to describe WMC which posed no difficulties in our grading why we do not believe this explains our results. Radiologists have been shown to be keener to report WMC which we believe is a more probable explanation to our results [14]. Our results would suggest that contextual reporting only had a significant effect on the reporting of MTA but the increased reporting of the other parameters would suggest that discrepancies in reporting styles were reduced to some extent. However, the low compliance with our contextual template and our assumption that reports with no mentioning of the evaluated parameters were normal may hamper such conclusions.
There are limitations to this study: (i) The use of two different cohorts could result in a potential bias from cohort effects. Differences in prevalence of abnormal findings were not significant between the groups but the observed prevalence was probably lower than would be expected in a memory clinic population. Our study population was derived from a population with cognitive impairment where none was diagnosed with dementia since we believe the clinical benefit from using VRS would be greater in this group [30, 31]. It cannot be excluded that an older study population or a memory clinic population would have yielded a higher prevalence of abnormal findings where a different compliance with our template cannot be excluded. (ii) Visual ratings are subjective and quantitative data such as volume segmentation would be preferable but are difficult to perform with NECT. We chose a gold standard based on high inter-rater agreement but this approach does not exclude a potential rater bias. (iii) The retrospective design hampers the possibility to obtain reliable data on potential effects of training, education, or individual experiences of using VRS among the neuroradiologists at our department. (iv) We have not compared our template with other structural reporting templates and we have not followed up on how the use of VRS affects the final diagnosis. (v) The use of the scale suggested by Torisson et al can be questioned. This is an attempt to grade the qualitative data in the radiology reports to make comparisons possible but the scale has not been tested for rater reliability, although it has been used in previous studies [12, 14].
This study adds knowledge to how reporting frequency of radiology findings can be improved in the diagnostic work up of cognitive impairment. Our results suggest that there is a possibility to increase the overall reporting of structural findings but only the results for MTA were significant. In conclusion, this study suggests that contextual radiological assessment using VRS could increase the reporting frequency of radiology findings in the diagnostic work up of cognitive impairment, but compliance with templates may be difficult to endorse.

Compliance with ethical standards

Guarantor

The scientific guarantor of this publication is Danielle van Westen.

Conflict of interest

The authors of this manuscript declare relationships with the following companies: O.H. has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Lilly, Roche, and Fujirebio. The other authors declare that they have no conflicts of interest.

Statistics and biometry

One of the authors has significant statistical expertise. No complex statistical methods were necessary for this paper.
Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Study subjects or cohorts overlap

Some study subjects or cohorts have been previously included in Håkansson et al (2019) Neuroradiology 61:397–404.

Methodology

• retrospective
• observational
• performed at one institution
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

e.Med Radiologie

Kombi-Abonnement

Mit e.Med Radiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Radiologie, den Premium-Inhalten der radiologischen Fachzeitschriften, inklusive einer gedruckten Radiologie-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Wallis A, McCoubrie P (2011) The radiology report – are we getting the message across? Clin Radiol 66:1015–1022CrossRef Wallis A, McCoubrie P (2011) The radiology report – are we getting the message across? Clin Radiol 66:1015–1022CrossRef
2.
Zurück zum Zitat Brady AP (2018) Radiology reporting – from Hemingway to HAL? Insights Imaging 9:237–246CrossRef Brady AP (2018) Radiology reporting – from Hemingway to HAL? Insights Imaging 9:237–246CrossRef
3.
Zurück zum Zitat Gagliardi RA (1995) The evolution of the X-ray report. AJR Am J Roentgenol 164:501–502 Gagliardi RA (1995) The evolution of the X-ray report. AJR Am J Roentgenol 164:501–502
4.
Zurück zum Zitat Larson DB, Towbin AJ, Pryor RM, Donnely LF (2013) Improving consistency in radiology reporting through the use of department-wide standardized structured reporting. Radiology 267:240–250CrossRef Larson DB, Towbin AJ, Pryor RM, Donnely LF (2013) Improving consistency in radiology reporting through the use of department-wide standardized structured reporting. Radiology 267:240–250CrossRef
5.
Zurück zum Zitat European Society of Radiology (ESR) (2018) ESR paper on structured reporting in radiology. Insights Imaging 9:1–7 European Society of Radiology (ESR) (2018) ESR paper on structured reporting in radiology. Insights Imaging 9:1–7
6.
Zurück zum Zitat Gunderman RB, McNeive LR (2014) Is structured reporting the answer? Radiology 273:7–9CrossRef Gunderman RB, McNeive LR (2014) Is structured reporting the answer? Radiology 273:7–9CrossRef
7.
Zurück zum Zitat Ganeshan D, Thi Duong PA, Probyn L et al (2018) Structured reporting in radiology. Acad Radiol 25:66–73CrossRef Ganeshan D, Thi Duong PA, Probyn L et al (2018) Structured reporting in radiology. Acad Radiol 25:66–73CrossRef
8.
Zurück zum Zitat Mamlouk MD, Chang PC, Saket RR (2018) Contextual radiology reporting: a new approach to neuroradiology structured templates. AJNR Am J Neuroradiol 39:1406–1414 Mamlouk MD, Chang PC, Saket RR (2018) Contextual radiology reporting: a new approach to neuroradiology structured templates. AJNR Am J Neuroradiol 39:1406–1414
9.
Zurück zum Zitat Wattjes MP, Henneman WJP, van der Flier WM et al (2009) Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector Row CT. Radiology 253:174–183CrossRef Wattjes MP, Henneman WJP, van der Flier WM et al (2009) Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector Row CT. Radiology 253:174–183CrossRef
10.
Zurück zum Zitat Harper L, Barkhof F, Fox NC, Schott JM (2015) Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiatry 86:1225–1233CrossRef Harper L, Barkhof F, Fox NC, Schott JM (2015) Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. J Neurol Neurosurg Psychiatry 86:1225–1233CrossRef
11.
Zurück zum Zitat Wahlund LO, Westman E, van Westen D et al (2017) Imaging biomarkers of dementia: recommended visual rating scales with teaching cases. Insights Imaging 8:79–90CrossRef Wahlund LO, Westman E, van Westen D et al (2017) Imaging biomarkers of dementia: recommended visual rating scales with teaching cases. Insights Imaging 8:79–90CrossRef
12.
Zurück zum Zitat Torisson G, van Westen D, Stavenow L, Minthon L, Londos E (2015) Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients. BMC Geriatr 15:65–72CrossRef Torisson G, van Westen D, Stavenow L, Minthon L, Londos E (2015) Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients. BMC Geriatr 15:65–72CrossRef
13.
Zurück zum Zitat Dewer B, Rogers P, Ricketts J, Mukonoweshuro W, Zeman A (2016) The radiological diagnosis of frontotemporal dementia in everyday practice: an audit of reports, review of diagnostic criteria, and proposal for service improvement. Clin Radiol 71:40–47CrossRef Dewer B, Rogers P, Ricketts J, Mukonoweshuro W, Zeman A (2016) The radiological diagnosis of frontotemporal dementia in everyday practice: an audit of reports, review of diagnostic criteria, and proposal for service improvement. Clin Radiol 71:40–47CrossRef
14.
Zurück zum Zitat Håkansson C, Torisson G, Londos E, Hansson O, van Westen D (2019) Structural imaging findings on non-enhanced computed tomography are severely underreported in the primary care diagnostic work-up of subjective cognitive decline. Neuroradiology 61:397–404CrossRef Håkansson C, Torisson G, Londos E, Hansson O, van Westen D (2019) Structural imaging findings on non-enhanced computed tomography are severely underreported in the primary care diagnostic work-up of subjective cognitive decline. Neuroradiology 61:397–404CrossRef
15.
Zurück zum Zitat Vernooij MW, Pizzini FB, Schmidt R et al (2019) Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group. Neuroradiology 61(6):633–642CrossRef Vernooij MW, Pizzini FB, Schmidt R et al (2019) Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group. Neuroradiology 61(6):633–642CrossRef
17.
Zurück zum Zitat Scheltens P, Leys D, Barkhof F et al (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967–972CrossRef Scheltens P, Leys D, Barkhof F et al (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967–972CrossRef
18.
Zurück zum Zitat Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool WA (1995) Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol 242:557–560CrossRef Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool WA (1995) Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol 242:557–560CrossRef
19.
Zurück zum Zitat Pasquier F, Leys D, Weerts JGE, Mounier-Vehier F, Barkhof F, Scheltens P (1996) Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36:268–272CrossRef Pasquier F, Leys D, Weerts JGE, Mounier-Vehier F, Barkhof F, Scheltens P (1996) Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol 36:268–272CrossRef
20.
Zurück zum Zitat Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149:351–356 Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 149:351–356
21.
Zurück zum Zitat Evans WA Jr (1942) An encephalographic ratio for estimating the size of cerebral ventricles: further experience with serial observations. Am J Dis Child 64:820–830CrossRef Evans WA Jr (1942) An encephalographic ratio for estimating the size of cerebral ventricles: further experience with serial observations. Am J Dis Child 64:820–830CrossRef
22.
Zurück zum Zitat Brix M, Westman E, Simmons A et al (2017) The Evans’ index revisited: new cut-off levels for use in radiological assessment of ventricular enlargement in the elderly. Eur J Radiol 95:28–32CrossRef Brix M, Westman E, Simmons A et al (2017) The Evans’ index revisited: new cut-off levels for use in radiological assessment of ventricular enlargement in the elderly. Eur J Radiol 95:28–32CrossRef
23.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRef
24.
Zurück zum Zitat Powell DK, Lin E, Silberzweig JE, Kagetsu NJ (2014) Introducing radiology report checklists among residents: adherence rates when suggesting versus requiring their use and early experience in improving accuracy. Acad Radiol 21:415–423CrossRef Powell DK, Lin E, Silberzweig JE, Kagetsu NJ (2014) Introducing radiology report checklists among residents: adherence rates when suggesting versus requiring their use and early experience in improving accuracy. Acad Radiol 21:415–423CrossRef
25.
Zurück zum Zitat Scheltens P, Fox N, Barkhof F, de Carli C (2002) Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 1(1):13–21CrossRef Scheltens P, Fox N, Barkhof F, de Carli C (2002) Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol 1(1):13–21CrossRef
26.
Zurück zum Zitat Bosmans JML, Weyler JJ, Parizel PM (2009) Structure and content of radiology reports, a quantitative and qualitative study in eight medical centers. Eur J Radiol 72:354–358CrossRef Bosmans JML, Weyler JJ, Parizel PM (2009) Structure and content of radiology reports, a quantitative and qualitative study in eight medical centers. Eur J Radiol 72:354–358CrossRef
27.
Zurück zum Zitat Wahlund LO, Julin P, Johansson SE, Scheltens P (2000) Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry 69:630–635CrossRef Wahlund LO, Julin P, Johansson SE, Scheltens P (2000) Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry 69:630–635CrossRef
28.
Zurück zum Zitat Galton CJ, Gomez-Anson B, Antoun N et al (2001) Temporal lobe rating scale: application to Alzheimer’s disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 70:165–173CrossRef Galton CJ, Gomez-Anson B, Antoun N et al (2001) Temporal lobe rating scale: application to Alzheimer’s disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 70:165–173CrossRef
29.
Zurück zum Zitat Cavallin L, Løken K, Engedal K et al (2012) Overtime reliability of medial temporal lobe atrophy rating in a clinical setting. Acta Radiol 53:318–323CrossRef Cavallin L, Løken K, Engedal K et al (2012) Overtime reliability of medial temporal lobe atrophy rating in a clinical setting. Acta Radiol 53:318–323CrossRef
30.
Zurück zum Zitat Rhodius-Meester HFM, Benedictus MR, Wattjes P et al (2017) MRI visual ratings of brain atrophy and white matter hyperintensities across the spectrum of cognitive decline are differently affected by age and diagnosis. Front Aging Neurosci 9:117CrossRef Rhodius-Meester HFM, Benedictus MR, Wattjes P et al (2017) MRI visual ratings of brain atrophy and white matter hyperintensities across the spectrum of cognitive decline are differently affected by age and diagnosis. Front Aging Neurosci 9:117CrossRef
31.
Zurück zum Zitat Claus JJ, Staekenborg SS, Holl DC et al (2017) Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: validation in a large memory clinic population. Eur Radiol 27:3147–3155CrossRef Claus JJ, Staekenborg SS, Holl DC et al (2017) Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer’s disease: validation in a large memory clinic population. Eur Radiol 27:3147–3155CrossRef
Metadaten
Titel
Reporting frequency of radiology findings increases after introducing visual rating scales in the primary care diagnostic work up of subjective and mild cognitive impairment
verfasst von
Claes Håkansson
Gustav Torisson
Elisabet Londos
Oskar Hansson
Isabella M. Björkman-Burtscher
Danielle van Westen
Publikationsdatum
26.08.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 2/2021
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-07180-2

Weitere Artikel der Ausgabe 2/2021

European Radiology 2/2021 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.